Medpage Today on MSN6d
Alzheimer's Patients May Gain Months of Independent Living With Treatment
Alzheimer's patients with a baseline CDR-SB score of 3.5 could expect approximately 4 additional months (95% CI 2-7 months) ...
Yale Daily News2d
Yale researchers developed AI tool to predict heart muscle disease
Founded in 2020, the CarDS Lab has been at the forefront of creating AI-based applications to improve medical diagnoses of ...
New Article Showing the Unique Mechanism of Action Behind Alzstatin as an Alzheimer's Treatment
STOCKHOLM, SWEDEN / ACCESS Newswire / February 24, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN ...
MedPage Today on MSN22h
Trump Team Fires Alzheimer's Staff; Herpesvirus and Alzheimer's; MS Drug Switches
Among those fired in the recent spate of Trump administration cuts are staff members at the NIH's Center for Alzheimer's and ...
AlzeCure Pharma: New Article Showing the Unique Mechanism of Action Behind Alzstatin as an Alzheimer's Treatment
STOCKHOLM, SWEDEN / ACCESS Newswire / February 24, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) ), a pharmaceutical company that develops candidate drugs for ...
StudyFinds on MSN1d
These drugs could give Alzheimer’s patients a longer life of independence, study shows
Explore the latest advancements in Alzheimer's treatment and the impact of new medications on patient independence and daily ...
Insurers Must Ditch Short-term Focus On Alzheimer's And Go For Zentara's Revolutionary Regime
Zentara, a groundbreaking new company, is pushing to steer the conversation away from these ineffective tactics to ...
LNTH: Earnings Report Next Week
LNTH READ THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) began 2025 with a pair of potentially ...
The two obstacles that are holding back Alzheimer’s research
There are two significant, nonscientific obstacles – a shortage of funding and patent law – that will require concerted effort by scientists, concerned citizens, society and our lawmakers to overcome.
El País in English3d
The ones who need little sleep
Short sleepers cruise by on four to six hours a night and don’t seem to suffer ill effects. Turns out they’re genetically ...
BridgeBio: Strong Commercial Momentum for Attruby Sets the Stage for Long-Term Profitability
BridgeBio possesses a medium revenue cyclicality rating, and its operating leverage has a low rating. We assess the company's balance sheet as weak due to management's dependence on debt issuance to ...